The CAR-T Therapy Shift: Redefining Second-Line Treatment Strategies in Multiple Myeloma : Episode 4

QOL Considerations for Optimal Patient Outcomes with CAR-T Therapy

January 31, 2025

By Rahul Banerjee, MD, FACP
Saad Z. Usmani, MD, MBA, FACP, FASCO

Opinion

Video

This video segment discusses strategies to help CAR-T therapy patients maintain quality of life, focusing on lifestyle support, balancing work during and after treatment, and effective supportive care measures.

EP: 1.Meet Sarah, a 55-year-old Businesswoman With Multiple Myeloma Considering CAR-T Therapy With Ide-cel

EP: 2.Managing Adverse Events with CAR T-Cell Therapy: Best Practices for Myeloma Care Teams

EP: 3.Managing Neurotoxicities in CAR T: Clinical Approaches and Patient/Caregiver Education

Now Viewing

EP: 4.QOL Considerations for Optimal Patient Outcomes with CAR-T Therapy

EP: 5.Getting to Know Robert, a 72-Year-Old Retired Teacher Facing a Myeloma Relapse and Considering CAR-T Therapy with Cilta-cel

EP: 6.Long-Term CAR-T Management in Myeloma: Collaborative Care and Monitoring Strategies for Patients Like Robert

EP: 7.Life After CAR T Therapy: Insights for Patients and Referring Oncologists

Video content above is prompted by the following:

Quality of life is crucial for patients undergoing CAR-T therapy: How do you help patients maintain their lifestyle and work during and after treatment? What supportive care measures have you found most beneficial?

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!